The Hartford Healthcare Fund Class Y (HGHYX)
Fund Assets | 1.02B |
Expense Ratio | 1.01% |
Min. Investment | $250,000 |
Turnover | 32.00% |
Dividend (ttm) | 1.90 |
Dividend Yield | 4.38% |
Dividend Growth | n/a |
Payout Frequency | Annual |
Ex-Dividend Date | n/a |
Previous Close | 43.03 |
YTD Return | -3.79% |
1-Year Return | -2.28% |
5-Year Return | 20.80% |
52-Week Low | 43.03 |
52-Week High | 52.56 |
Beta (5Y) | 0.73 |
Holdings | 108 |
Inception Date | Apr 28, 2000 |
About HGHYX
The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
Performance
HGHYX had a total return of -2.28% in the past year. Since the fund's inception, the average annual return has been 10.34%, including dividends.
Top 10 Holdings
45.67% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 10.97% |
UnitedHealth Group Incorporated | UNH | 9.62% |
Merck & Co., Inc. | MRK | 4.14% |
Intuitive Surgical, Inc. | ISRG | 3.92% |
Boston Scientific Corporation | BSX | 3.68% |
Danaher Corporation | DHR | 3.56% |
Thermo Fisher Scientific Inc. | TMO | 2.84% |
Vertex Pharmaceuticals Incorporated | VRTX | 2.73% |
HCA Healthcare, Inc. | HCA | 2.18% |
Johnson & Johnson | JNJ | 2.02% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
Dec 10, 2019 | $2.36232 | Dec 11, 2019 |
Dec 17, 2018 | $2.4841 | Dec 18, 2018 |